Cyclosporine in rheumatoid arthritis. 1995

D E Yocum, and H Torley
Section of Rheumatology and Immunology, University of Arizona Arthritis Center, Tucson 85724, USA.

Rheumatoid arthritis is a chronic inflammatory process of unknown etiology that leads to significant morbidity and accelerated mortality in the 10 to 15% of patients with severe proliferative and erosive synovitis that is unresponsive to conventional therapies. T cells play a key role in the initiation and perpetuation of the process. Based on its immune action, cyclosporine has been used in rheumatoid arthritis in a variety of worldwide clinical trials. This article presents the results of several pivotal studies and outlines the development of cyclosporine in the treatment of rheumatoid arthritis.

UI MeSH Term Description Entries
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D016572 Cyclosporine A cyclic undecapeptide from an extract of soil fungi. It is a powerful immunosupressant with a specific action on T-lymphocytes. It is used for the prophylaxis of graft rejection in organ and tissue transplantation. (From Martindale, The Extra Pharmacopoeia, 30th ed). Cyclosporin A,Ciclosporin,CsA-Neoral,CyA-NOF,Cyclosporin,Cyclosporine A,Neoral,OL 27-400,Sandimmun,Sandimmun Neoral,Sandimmune,CsA Neoral,CsANeoral,CyA NOF,OL 27 400,OL 27400

Related Publications

D E Yocum, and H Torley
August 1992, Seminars in arthritis and rheumatism,
D E Yocum, and H Torley
January 2000, The Cochrane database of systematic reviews,
D E Yocum, and H Torley
January 1988, Springer seminars in immunopathology,
D E Yocum, and H Torley
June 1992, Seminars in arthritis and rheumatism,
D E Yocum, and H Torley
January 1993, The Annals of pharmacotherapy,
D E Yocum, and H Torley
September 1995, Clinical rheumatology,
D E Yocum, and H Torley
January 1996, The Journal of rheumatology,
D E Yocum, and H Torley
January 1991, The Journal of rheumatology,
D E Yocum, and H Torley
January 2004, Clinical and experimental rheumatology,
D E Yocum, and H Torley
January 1990, The Journal of rheumatology,
Copied contents to your clipboard!